Angiotensin Receptor-Neprilysin Inhibitor Therapy for Heart Failure With Preserved Ejection Fraction Improves Renal Outcomes. Tobe SW, Poon S. Circulation 2020;142:1246-1248.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tobe SW, Poon S. Angiotensin Receptor-Neprilysin Inhibitor Therapy for Heart Failure With Preserved Ejection Fraction Improves Renal Outcomes. Circulation 2020;142:1246-1248.
PMID: 32986477